http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108743866-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-55
filingDate 2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108743866-B
titleOfInvention Hongbao heart-soothing oral liquid and application thereof in preparation of cardiovascular disease drugs
abstract The invention discloses a Hongbao Shuxin oral liquid and application thereof in preparation of drugs for treating cardiovascular diseases, comprising 10-15 parts of black wolfberry, 15-20 parts of Kulu wood extract, 1-2 parts of musk, 1-3 parts of rose, 3-4 parts of tabasheer, 1-2 parts of ruby, 1-2 parts of sandalwood, 1-2 parts of amber, 3-4 parts of borage, 1-2 parts of pearl, 3-5 parts of saffron, 1-2 parts of moldavica dragonhead, 2-3 parts of cassia seed, 3-4 parts of silkworm cocoon, 1-2 parts of oldenlandia diffusa, 3-4 parts of tsaoko amomum fruit, 1-2 parts of coral, 1-2 parts of celery seed, 2-3 parts of purslane seed, 4-5 parts of cassia seed, 1-2 parts of Ocimum gratissimum and 1-2 parts of usnea; the prepared Hongbao Shuxin oral liquid is applied to medicaments for treating cardiovascular diseases, the blood pressure is obviously reduced in a rat experiment, in the clinical treatment evaluation of coronary heart disease, the total effective rate of the Hongbao Shuxin oral liquid group provided by the invention is 91.67 percent, the total effective rate of the Hongbao Shuxin ancient formula group is 78.33 percent, the total effective rate of the prepared Hongbao Shuxin oral liquid group is obviously higher than that of the Hongbao Shuxin ancient formula group, and the clinical use effect is remarkable.
priorityDate 2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 56.